Perimenopause with Migraines: Why They Get Worse and What Helps
How hormonal migraines worsen during perimenopause, the role of HRT, menstrual migraine triggers, and evidence-based management strategies.
Why Perimenopause Is a Peak Time for Migraines
Migraine is strongly linked to fluctuating oestrogen levels, and perimenopause is a time of dramatic hormonal variability. For women who already experience hormonal migraines, the erratic rises and falls in oestrogen during perimenopause can make this one of the worst periods of their migraine history. Drops in oestrogen are a particularly potent trigger, and perimenopause is characterised by repeated, unpredictable oestrogen dips as ovarian function becomes inconsistent. Even women who have never previously experienced migraines can develop them for the first time during perimenopause, and women whose migraines were manageable before may find them becoming more frequent, longer-lasting, or more resistant to their usual treatments. Research shows that migraine prevalence in women peaks in the late forties, which aligns closely with the typical perimenopausal window. Understanding that this worsening is hormonally driven, rather than a sign that something else is wrong, is an important first step toward getting appropriate help.
Menstrual Migraine and Perimenopause
Menstrual migraine is a specific type of migraine that occurs in a predictable window around the time of menstruation, typically in the two days before and the first three days of a period. It is driven by the natural drop in oestrogen that occurs at the end of the luteal phase, and it is often more severe, longer-lasting, and less responsive to standard triptan treatment than migraines at other times of the month. During perimenopause, cycles become irregular and oestrogen drops become less predictable, which means that menstrual migraines may spread beyond their usual window and occur at other points in the cycle too. Some women find that their menstrual migraines actually improve once periods stop entirely, because the hormonal environment becomes more stable. But in the years before that stability is reached, the unpredictability of perimenopausal cycles can feel like an escalation rather than a winding down. Keeping a headache diary linked to your cycle, even when cycles are irregular, helps identify patterns and informs treatment decisions.
HRT: A Complex Balancing Act for Migraine Sufferers
Hormone replacement therapy has a complicated relationship with migraine, and the evidence does not point in one simple direction. Some women find that steady-state transdermal oestrogen (gel or patches), which avoids the peaks and troughs of oral oestrogen, actually reduces migraine frequency by stabilising the hormonal environment. Others find that HRT worsens their migraines, particularly if they experience the oestrogen peak after application or if the progesterone component is a trigger. The type of progesterone matters: micronised progesterone tends to be better tolerated by migraineurs than synthetic progestogens, which can themselves be migraine triggers. For women who experience migraine with aura, combined oral contraceptives are contraindicated due to a small but real increased stroke risk. This restriction does not apply to transdermal HRT in the same way, but it is still important to discuss your migraine type with your prescriber before starting HRT. Getting this conversation right can make a significant difference to both your migraine and your perimenopausal symptoms.
Acute Treatment and Prevention Strategies
Managing migraines during perimenopause usually involves a combination of acute and preventive strategies. Triptans remain the most effective acute treatment for migraine attacks and continue to work well during perimenopause, though some women need to adjust their dose or switch to a longer-acting formulation as their attacks change character. Anti-nausea medications used alongside triptans improve both nausea symptoms and triptan absorption. For women whose migraines are becoming more frequent, preventive medication may be warranted. Options include propranolol, amitriptyline, topiramate, and the newer anti-CGRP medications (such as erenumab and fremanezumab), which have shown good evidence in women with hormonal migraine. Non-pharmacological prevention includes regular sleep, consistent meal timing, limiting alcohol and caffeine, and stress management. CGRP injections and devices such as Cefaly (transcutaneous electrical nerve stimulation) are worth discussing with a neurologist or headache specialist if standard treatments are not providing adequate control.
Identifying and Managing Perimenopausal Migraine Triggers
Perimenopause introduces several new or worsened migraine triggers that are worth understanding and addressing where possible. Poor sleep, which becomes common as night sweats and anxiety disrupt rest, is one of the most potent migraine triggers, and addressing sleep problems is part of migraine management, not a separate issue. Dehydration worsens during perimenopause partly because night sweats increase fluid loss, and staying well hydrated is a basic but meaningful migraine prevention step. Alcohol sensitivity often increases during perimenopause, and what was previously a tolerable amount of wine may now reliably trigger a migraine the following day. Caffeine presents a double-edged situation: it can help abort an early attack but causes rebound headache if used too frequently. Stress and the cortisol fluctuations that come with it are significant contributors, and finding consistent ways to modulate the stress response pays off in migraine frequency as well as general wellbeing.
Getting the Right Help and Specialist Support
Women with frequent or severe migraines during perimenopause are best served by coordinated care between their GP, a neurologist or headache specialist, and ideally a menopause specialist. Too often, migraines are treated in isolation without reference to the hormonal context, or perimenopausal HRT is adjusted without considering its impact on migraine. The British Association for the Study of Headache (BASH) guidelines and those from the International Headache Society both acknowledge the specific challenges of hormonal migraine management in perimenopause. If your GP is not familiar with this intersection, it is entirely reasonable to ask for a referral to a headache clinic or a menopause clinic that has experience in this area. The Migraine Trust and The Menopause Charity both provide accessible resources for women navigating this combination of conditions. You should not have to choose between treating your migraines and treating your perimenopausal symptoms; with the right expertise, both can be addressed in a coordinated way.
Related reading
Get your personalized daily plan
Track symptoms, match workouts to your day type, and build a routine that adapts with you through every phase of perimenopause.